About Careers MedBlog Contact us

Piramal Initiates Phase II Trial of Diabetes Drug

by Kathy Jones on September 20, 2010 at 8:30 PM
Font : A-A+

 Piramal Initiates Phase II Trial of Diabetes Drug

One of India's leading pharmaceutical companies, Piramal Life Sciences has announced that it has started the phase-II study into its upcoming diabetic drug.

The company's Managing Director Somesh Sharma revealed that the phase-II study of 'P1736-05' has been started and the company was confident of a successful completion of the study.


The P1736-05 is an insulin sensitizing compound which will be a part of the company's new drug for the treatment of type-2 diabetes in India and Europe.

"The commencement of phase-II trial of P1736-05 in India and Europe speaks of our efforts to build a diversified and strong pipeline of products to address unmet medical needs. P1736-05 is likely to provide a safe and effective therapeutic option to type-2 diabetic patients", Sharma added.

Source: Medindia


Recommended Reading

Latest Clinical Trials News

 Gene Therapy Using Adeno Virus Reverses Age-Related Hearing Loss
Researchers tested the effectiveness of virus-mediated gene therapy for genetic hearing loss in an aged mouse model with genetic changes related to deafness.
Stickers Promise a Painless Mode of Measles Vaccine Delivery
The outcomes of the first clinical trial demonstrate the safety and efficacy of the measles-rubella (MR) vaccination to adults and infants as young as 9 months.
 New Wearable Ultrasound Device Monitors Deep-Tissues in Moving Subjects
Scientists devise a fully integrated autonomous wearable ultrasonic-system-on-patch to sense deep tissue vital signs wirelessly even when the patient is on the move.
Exploring the Benefits of a Chemotherapy Regimen Following Pancreatic Cancer Surgery
Combination of chemotherapy drugs was found to show promising results in patients with pancreatic cancer.
 Dirty-bomb Antidote: Drug Trial Beings to Remove Radioactive Contamination
A new clinical trial is testing the safety, tolerability, and processing in the body of drug product HOPO 14-1 that removes radioactive contamination in healthy adults.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Piramal Initiates Phase II Trial of Diabetes Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests